Competitive Positioning

Introducing
Predictive, Competitive Positioning

The first solution to predict clinical trial and commercial outcomes for an asset compared to the competition, while it is still in development

Request a demo Explore use cases

A one-of-a-kind solution that bridges clinical development and commercial strategy

By integrating clinical and commercial intelligence into R&D, organizations can make more informed decisions across portfolio management, strategy, trial design, evidence generation, and go-to-market planning — while assets are still in early clinical development.

Life sciences demands predictive positioning

Traditional competitive intelligence explains what happened. Predictive positioning helps teams anticipate what happens next, enabling smarter clinical, portfolio, and commercial decisions.

1:3

drugs miss their launch forecasts

57%

of drug launches fail due to poor understanding of market and customer needs

40%+

of drug launch failures are attributed to poor product differentiation

Features

Predict Competitor Performance

For any indication, monitor competitive Phase 2 and Phase 3 trials to understand the potential of their mechanisms of action (MOAs), target patient populations, and safety and efficacy profiles.

Simulate Category-Wide Trial Outcomes

For investigational and marketed therapies, understand how an asset’s safety and efficacy profile compares with competitors, enabling smarter, more differentiated clinical trial design

Drive Commercial Advantage

Simulate direct comparisons between your asset and competing therapies across patient subpopulations, biomarkers, and market segments, helping you identify key differentiators and develop an effective positioning strategy

Use Cases

Clinical Development

Design trials built to succeed

Evaluate likely outcomes, competitive differentiation, and enrollment feasibility early in development to optimize study design, reduce risk, accelerate timelines, and improve the likelihood of clinical and commercial success.

Franchise and Market Strategy

Make smarter portfolio and commercialization decisions

Understand future market dynamics, identify the highest-value opportunities, refine product positioning, and build more accurate forecasts to maximize commercial success.

Competitive Intelligence

Make faster, more strategic competitive decisions

Identify emerging competitor threats, anticipate likely trial outcomes, and assess competitive programs with greater confidence, enabling proactive strategy and more impactful insights.

Executive Leadership

Make high-stakes investment decisions with confidence

Quantify a drug's market potential before a single patient is enrolled, helping you evaluate opportunities, prioritize investments, and make more informed go/no-go licensing and business development decisions.

Industry Feedback

Trusted by three of the world’s top 20 pharmaceutical companies across competitive intelligence, clinical development, and commercial strategy teams

Schedule a demo

How It Works

Predict Clinical Outcomes Before They Happen

Use the industry's leading clinical trial foundation model trained on more than 100 million patient records and validated across 600+ completed clinical trials – to forecast trial-level and patient-subpopulation outcomes for assets in development and on the market.

Build a Future Competitive Landscape

Evaluate competitive therapies – with no sponsor data required – and gain visibility into how competing assets are likely to perform, where they may succeed, and how the market may evolve over time.

Identify the Best Positioning Strategy

Combine predicted clinical outcomes with competitive, market, and patient insights to help determine the optimal target patient population, clinical strategy, and market positioning for each asset.

Make Better Decisions Across the Product Lifecycle

Unify R&D, competitive intelligence, and commercial strategy teams around a shared, predictive view of the future.